Compass Therapeutics, Inc.

NASDAQ:CMPX

2.62 (USD) • At close July 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -49.375-42.494-39.225-82.181-29.5-34.744-38.286
Depreciation & Amortization 1.7531.891.9041.6242.4042.121.921
Deferred Income Tax 00050.5760.8370.109-0.261
Stock Based Compensation 8.566.125.334.0294.0160.9150.656
Change In Working Capital -4.142-2.908-1.2636.245-3.6-0.2572.17
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables -1.8410.7082.515-0.1940.432-1.1010.992
Other Working Capital -2.301-3.616-3.7786.439-4.0320.8441.178
Other Non Cash Items -1.6515.966-0.8710.041-0.960.1160.121
Operating Cash Flow -44.855-40.618-34.125-19.666-26.803-31.741-33.679
Investing Activities:
Investments In Property Plant And Equipment -0.044-0.03-0.212-1.568-0.106-0.466-2.02
Acquisitions Net 000.1760.1160.14400
Purchases Of Investments -88.158-155.418-200.1190000
Sales Maturities Of Investments 134.974182.41348.9550000
Other Investing Activites 00.027-0.151-0.318000
Investing Cash Flow 46.77226.965-151.2-1.770.038-0.466-2.02
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 18.1133.09476.237128.26760.482049.077
Common Stock Repurchased 0-000000
Dividends Paid 0000000
Other Financing Activities -0.775-0.159-0.48-0.281-6.3190.03864.031
Financing Cash Flow 17.3382.93575.757118.61148.5380.03864.031
Other Information:
Effect Of Forex Changes On Cash 00000-0.0380
Net Change In Cash 19.255-10.718-109.56897.17521.773-32.20728.332
Cash At End Of Period 43.48324.22834.946144.51447.33925.56657.773